Kingston, United Kingdom

John Scott Lloyd

This inventor holds 1 USPTO granted patent. Top assignee: British Biocell International Limited. Active years: 2006.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Scott Lloyd: Innovator in Nucleic Acid Detection

Introduction

John Scott Lloyd is a notable inventor based in King Sutton, GB. He has made significant contributions to the field of molecular biology, particularly in the detection of nucleic acid target sequences. His innovative approach has led to the development of a unique method that enhances the accuracy and efficiency of nucleic acid detection.

Latest Patents

John Scott Lloyd holds a patent for a method involving in vitro transcription from an RNA polymerase promoter. This patent describes a complex formed by a hybridization reaction that includes four nucleic acid molecules. The complex consists of a target nucleic acid molecule and three probe molecules, each designed to hybridize with specific regions of the target. The formation of this complex results in a functional double-stranded RNA polymerase promoter, which is crucial for detecting target nucleic acid sequences.

Career Highlights

Throughout his career, John has been associated with British Biocell International Limited, where he has applied his expertise in molecular biology. His work has contributed to advancements in the field, particularly in the development of methods for nucleic acid detection.

Collaborations

John has collaborated with notable colleagues, including Anthony Lee Weston and Donald Leonard Nicholas Cardy. These collaborations have further enriched his research and innovation in the field.

Conclusion

John Scott Lloyd is a distinguished inventor whose work in nucleic acid detection has paved the way for advancements in molecular biology. His innovative methods and collaborations continue to influence the field significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…